Dr. Mudhasir Ahmad

About Doctor

• Dr. Mudhasir Ahmad is a renowned Medical Oncologist with experience of more than 14 years
• He has expertise in the treatment of Immunotherapy, Targeted therapy, and genetic mutation-based therapy, and cancers of the breast, gynecological (ovarian, cervix, uterine), lung, gastrointestinal, head and neck, lymphomas, myeloma, molecular therapy, endocrine therapy and advanced chemotherapy.
• He is an active member of the American Society of medical oncology, European Society of Medical Oncology, Medical oncologists federation of A P, India, International Association for the Study of Lung Cancer, Indian society of medical and pediatric oncology and Delhi Oncology Forum.
• He has received the Indian Council of Medical Research (ICMR) grant for a research presentation in Barcelona, Spain.
• Dr. Ahmad has several publications in international as well as national journals.

Qualifications

• DNB

• MD

• MBBS

Experience

• Consultant, Fortis Escorts Hospital, Faridabad
• Consultant, HCG (Healthcare Global), Delhi
• Consultant, Apollo Hospitals, Jubilee Hills Hyderabad
• Senior Registrar, Indraprastha Apollo Hospital, New Delhi

Specialization and Expertise

Malignant hematology, Immunotherapy, Targeted therapy

Memberships & Certifications

Awards & Accomplishments

• Hospital-based observational study on the tolerability, and efficacy of two Gemcitabine Oxaliplatin regimens Abstract. Annals of Oncology 24 (4): iv38–iv121, 2013
• Hypercvad+Bortezomib Is a Well Tolerated Salvage Regimen for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia. Blood (ASH- American Society of Hematology- Annual Meeting Abstracts) 2010 116: Abstract 4345.
• High Sensitivity C- Reactive Protein in the Male Patients with Angina with Normal Coronary Arteries. IJHSR. 2014; 4(4): 69-79
• An Unusual Case of Refractory Seizure Disorder; An Insight into the Cause of Delayed Presentation of Functional Insulinoma. Austral – Asian Journal of Cancer ISSN-0972-2556, Vol. 13, No. 2, April 2014
• Pulmonary artery thrombosis mimicking disease progression in metastatic renal cell carcinoma while on sunitinib. Published in Indian Journal of cancer in Jan-Mar, 2016, and a poster presentation in 31st ICON CONFERENCE Bhopal, MP, India. September 12, 2014. DOI: 10.4103/0019-509X.180852
• Posterior reversible encephalopathy syndrome, the most uncommon adverse effect of one the commonest chemotherapy regimens, FOLFOX. Apollo Medicine March 2015. Published by Elsevier. Apollo medicine 12 (2015) 54-5 6
• Infections in Hematopoietic Stem Cell Transplantation Recipients in the Pre-Engraftment Period. Global Journal of Hematology and Blood Transfusion, 09 January 2015. ISSN (online): 2408-9877